Merck, 1235820-300MG, Enoxaparin sodium

General description
Enoxaparin Sodium is the sodium salt of a depolymerized heparin. It consists of a complex set of oligosaccharides that have not yet been completely characterized. Most of the components have a 4-enopyranose uronate structure at the nonreducing end of their chain. About 20% of the materials contain a 1,6-anhydro derivative on the reducing end of the chain, the range being between 15% and 25%. Enoxaparin sodium USP reference standard is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Enoxaparin sodium is a low molecular weight heparin (LMWH) used for thromboprophylaxis and anticoagulant therapy. It acts by potentiating antithrombin III to inhibit Factor Xa. The USP reference standard supports bioassays, potency testing, and structural analysis of LMWH preparations.

The USP biologics carbohydrates category includes a variety of carbohydrate-based substances that are essential in the development and manufacturing of therapeutic products. These carbohydrates play crucial roles in biological processes and are often utilized as excipients, stabilizers, or active ingredients in pharmaceuticals. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of carbohydrate therapeutics throughout their lifecycle.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application
Enoxaparin sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Enoxaparin Sodium Injection

Other Notes
Enoxaparin Sodium is the sodium salt of a depolymerized heparin. It consists of a complex set of oligosaccharides that have not yet been completely characterized. Most of the components have a 4-enopyranose uronate structure at the nonreducing end of their chain. About 20% of the materials contain a 1,6-anhydro derivative on the reducing end of the chain, the range being between 15% and 25%. Enoxaparin sodium USP reference standard is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Technical Article available
Enoxaparin Sodium is the sodium salt of a depolymerized heparin. It consists of a complex set of oligosaccharides that have not yet been completely characterized. Most of the components have a 4-enopyranose uronate structure at the nonreducing end of thei
Sales restrictions may apply.
This product is part of the USP Biologics program.